FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes

Merilog administered subcutaneously five to 10 minutes before mealtime helps improve glycemic control

Merilog administered subcutaneously five to 10 minutes before mealtime helps improve glycemic control